Human Siglec-5/CD170 Antibody, R&D Systems™

Siglec-5/CD170

LYOPH

Western Blot, Immunohistochemistry

Unconjugated

Mouse

Human

O15389

8778

Mouse myeloma cell line NS0-derived recombinant human Siglec-5/CD170 Lys18-Thr434 Accession # O15389

Primary

Reconstitute at 0.5 mg/mL in sterile PBS.

Detects human Siglec-5/CD170 in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human Siglec-2, -3, -7, -9, or -14 is observed.

194117

Western Blot 1 ug/mL, Immunohistochemistry 8-25 ug/mL

Monoclonal

Purified

RUO

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

CD170, CD170 antigen, CD33 antigen-like 2, CD33L2, CD33L2OB binding protein-2, OBBP2, OB-BP2OB-binding protein 2, OBBP2sialic acid-binding Ig-like lectin 5, Obesity-binding protein 2, sialic acid binding Ig-like lectin 5, sialic acid-binding immunoglobulin-like lectin 5, Siglec5, SIGLEC-5

SIGLEC5

IgG2b

Protein A or G purified from hybridoma culture supernatant

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.